Clinical Trials Browser

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Leukemia, Mast-Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Sezary Syndrome, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Central Nervous System Neoplasms, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis, Intraocular Lymphoma

NCT00001337 2025-06-22

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Phase 2 Completed

348 enrolled 15 charts

Lymphoid

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

NCT02810873 2025-05-04

Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer

Phase NA Terminated

19 enrolled 7 charts

Breast

Breast Neoplasms

NCT03824535 2025-04-09

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

Phase 2 Completed

15 enrolled 7 charts

Smoking Cessation, Multiple Pulmonary Nodules

NCT05753995 2025-04-01

Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study

Phase NA Active not recruiting

20 enrolled

CNS

Glioblastoma

NCT04053842 2025-03-13

IGPC-5

Phase 2 Active not recruiting

45 enrolled

Genitourinary

Prostatic Neoplasms

NCT04186819 2025-02-26

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Phase 3 Completed

356 enrolled 28 charts

Genitourinary

Disease, Prostatic Neoplasms

NCT04510311 2025-01-10

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

Phase EARLY_PHASE1 Completed

32 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT03054792 2024-12-13

Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas

Phase 1 Enrolling by invitation

18 enrolled

Sarcoma

Rhabdomyosarcoma, Sarcoma

NCT02023996 2024-12-10

PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer

Phase NA Completed

42 enrolled 11 charts

Gastrointestinal

Esophagogastric Cancer

NCT05632601 2024-11-04

HER-CROWN

Phase NA Recruiting

210 enrolled

BreastGynecologic

Breast Neoplasms, Cardiovascular Diseases, Polycystic Ovary Syndrome, Toxemia, Diabetes, Gestational, Primary Ovarian Insufficiency

NCT05662540 2024-10-26

PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma

Phase NA Recruiting

40 enrolled

Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT06586047 2024-09-19

Breast Cancer PSMA PET

Phase NA Recruiting

30 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02492867 2024-09-03

A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer

Phase NA Completed

49 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02683824 2023-09-21

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

Phase EARLY_PHASE1 Completed

21 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02809690 2023-09-07

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

Phase 1 Terminated

18 enrolled

Genitourinary

Prostatic Neoplasms

NCT03244566 2023-07-13

PET in Guiding Cervical Lymphadenectomy (ECTOP-2003)

Completed

110 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT04521894 2023-06-09

The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer

Unknown

500 enrolled

Genitourinary

Prostatic Neoplasms

NCT03371420 2023-04-18

PET Imaging of Subjects Using 124I-PU-AD

Phase EARLY_PHASE1 Terminated

5 enrolled

LymphoidPlasma cell

Alzheimer Disease, Lymphoma, Neoplasms, Plasma Cell

NCT04554719 2023-02-14

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Phase NA Unknown

500 enrolled

Tumor-Agnostic

Neoplasms

NCT05006326 2023-02-14

Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma

Phase NA Unknown

30 enrolled

Tumor-Agnostic

Neoplasms

NCT02414750 2022-11-30

REPOSIT

Phase 2 Terminated

78 enrolled

Dermatologic

Melanoma

Clinical Trials

Using Diagnostic Tools to Stage Breast Cancer

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

Detecting HPV DNA in Anal and Cervical Cancers

Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

Pediatric PET/MR Image Registry

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones

RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

MR Microstructural Imaging for Prostate Cancer Diagnosis

RefleXion PET/CT Imaging Performance in Patients With Various Malignancies

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4

A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy

CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence

A Study of Patients Receiving High-Dose Rate Brachytherapy

Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

A Study of Metabolic Agents Following Brain Radiation

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study

IGPC-5

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas

PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer

HER-CROWN

PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma

Breast Cancer PSMA PET

A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

PET in Guiding Cervical Lymphadenectomy (ECTOP-2003)

The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer

PET Imaging of Subjects Using 124I-PU-AD

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma

REPOSIT